CD44 and cancer: Further, the taxane-resistant DUTXR also showed enrichment of biomarkers that play significant roles in cancer progression, development, and maintenance of cancer stemness (CD44; Figure 2E,F) and drug resistance (CDK1, CXCL8; Figure 2G), indicating probable involvement of these genes in mCRPC development and progression [38].